Anti-melanoma antibody MG-21 for diagnosis and therapy of human

Details Anti-melanoma antibody MG-21 for diagnosis and therapy of human Anti-melanoma antibody MG-21 for diagnosis and therapy of human

1986-02-20

1991-10-08

Draper, Garnette D.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

43524027, 435188, 530389, 530390, 530391, 424 8591, 424 858, 424 11, 436548, A61K 3516, C12N 1506

Patent

active

050555596

ABSTRACT:
An antibody MG-21 which is directed against a tumor-associated glycolipid antigen and which is capable of activating serum complement or antibody dependent cellular cytoxicity is described. This antibody finds use in the therapy of cancers particularly melanoma and glioma. Proper administration of the antibody results in lysis of the tumor cells in vivo.

REFERENCES:
Hellstrom et al., 1985, Proc. Natl. Acad. Sci. 82:1499-1502.
Hellstrom et al., 1985, Monoclonal Antibodies and Cancer Therapy, (USCLA Symp. on Molec. and Cell. Biol., Alan R. Liss) pp. 149-164.
Hellstrom and Hellstrom in Accomplishments in Cancer Research 1985, 194:216-240 (J. F. Fortner, J. E. Rhoads, J. B. Lippincott. Co.).
Hellstrom et al., 1984, Contrib. to Oncol. Series: Genes and Antigens in Cancer Cells (Reithmuller, Koprowski, Van Kliest & Munk), pp. 121-131.
Dippold et al., 1983, Cancer Res., 44:806-901.
Burchell et al., in Monoclonal Antibodies for Tumor Detection and Drug Targeting (R. W. Baldwin & V. S. Byers, Acad. Press, 1985), pp. 1-15.
Hakomori, 1984, Ann. Rev. Immunol., 2:103-126.
Nepom, 1984, Proc. Natl. Acad. Sci., 81:2864-2867.
Koprowski et al., 1984, Proc. Natl. Acad. Sci., 81:216-219.
Hellstrom et al., 1983, J. Immunol., 130:1467-1472.
Nudelman et al., 1982, J. Biol. Chem., 257:12752-12756.
Brown et al., 1981, J. Immunol., 127:539-546.
Colcher et al., 1981, Cancer Res., 41:1451-1459.
Woodbury et al., 1980, Proc. Natl. Acad. Sci., 77:2183-2186.
Schulz et al., 1983, Proc. Natl. Acad. Sci., 80:5407-5411.
Fidler and Poste, 1982, Springer Semin. Immunopathol. 5:161-174.
Hellstrom et al., 1981, Int. J. Cancer, 27:281-285.
Uananue and Benacerraf, 1984, Text. Immunol. (Williams & Wilkins, Chapter (12)) pp. 218-238.
Julius et al., 1973, Eur. J. Immunol., 3:645-649.
Pollack et al., 1972, Int. J. Cancer, 9:316-323.
Skurzak et al., 1972, J. Exp. Med. 135:997-1002.
MacLennan et al., 1969, Immunol. 17:897-910.
Perlmann et al., 1969, Adv. Immunol. 11:117-193.
Hellstrom et al., 1965, Progr. Allergy 9:158-245.
Rowland et al., 1985, Cancer. Immunol. Immunother., 19:1-7.
DeNardo et al., 1985, Int. J. Radiation Oncology Biol. Phys., 11:335-348.
Kemshead in Monoclonal Antibodies for Tumor Detection and Drug Targeting (R. W. Baldwin & V. S. Byers, Academic Press, 1985) pp. 281-302.
Vitetta and Uhr, 1984, Transplant., 37:535-538.
Carrasquillo et al., 1984, Cancer Treatment Reports, 68:317-328.
Larson et al., 1983, J. Clin. Invest. 72:2101-2114.
Yeh et al., 1982, J. Cancer, 29:269-275.
Garrigues et al., 1982, Int. J. Cancer, 29:511-515.
Jansen et al., 1982, Immunol. Rev., 62:185-216.
Brown et al., 1981, Proc. Natl. Acad. Sci., 78:539-543.
Brown et al., 1979, J. Immunol. Meth., 31:201-209.
Hurwitz et al., 1975, Cancer Res., 35:1175-1181.
Cole et al., 1985, in Monoclonal Antibodies and Cancer Therapy (Alan R. Liss) pp. 77-96.
Takeda et al., 1985, Nature, 314:452-454.
Neuberger et al., 1984, Nature, 312:604-608.
Morrison et al., 1984, Proc. Natl. Acad. Sci., 81:6851-6855.
Cote et al., 1983, Proc. Natl. Acad. Sci., 80:2026-2030.
Pukel, C. S. et al., "G.sub.D3, a Prominent Ganglioside of Human Melanoma, Detection and Characterization by Mouse Monoclonal Antibody", J. Exp. Med. 155: 1133-1147, Apr. 1982.
Dippold, W. G. et al. (I), "Inhibition of Human Melanoma Cell Growth in vitro by Monoclonal Anti-GD.sub.3 -Ganglioside Antibody", Cancer Research 44, 806-810, Feb. 1984.
Dippold, W. G. et al. (II), "Cell Surface Antigens of Human Malignant Melanoma: Definition of Six Antigenic Systems with Mounse Monoclonal Antibodies", Proc. Nat'l Acad. Sci. 77(10): 6114-6118, Oct. 1980.
Cheresh, D. A. et al., "Disialoganglioside GD3 on a Human Melanoma Serves as a Relevant Target Antigen for Monoclonal Antibody-Mediated Tumor Cytolysis", Proc. Nat'l Acad. Sci. 82: 5155-5159, Aug. 1985.
Ochi, A. et al., "Transfer of a Cloned Immunoglobulin Light-Chain Gene to Mutant Hydridoma Cells Restores Specific Antibody Production", Nature 302: 340-342, 1983.
Cerrottini et al., 1974, Adv. Immunol., 18:67-132.
Order, 1984, Comp. Ther. 10:9-18.
Ghose et al., 1972, Brit. Med. J., 3:495-499.
Ey et al., 1978, Immunochemistry, 15:429-436.
Kohler & Milstein, 1975, Nature, 256:495-497.

Affiliated with

Also associated with

Rating

Anti-melanoma antibody MG-21 for diagnosis and therapy of human does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-melanoma antibody MG-21 for diagnosis and therapy of human , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-melanoma antibody MG-21 for diagnosis and therapy of human will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-257790